Danger Zone Call Featured In SumZero Face Off

SumZero recently featured our analysis on the multitude of issues facing Valeant Pharmaceuticals (VRX). In a “Fund Face Off,” our short analysis was pitted against the long analysis from Navi Hehar of Mile 26 Capital. Read the entire “Fund Face Off” here.